TrumpRx

Product

Last mentioned: Feb 25, 2026

Timeline

  1. Operational Launch

    The North Chicago facilities are expected to begin full-scale API production.

  2. Construction Start

    Groundbreaking expected for the two new advanced manufacturing sites.

  3. Manufacturing Expansion

    AbbVie announces $380M investment for North Chicago API facilities.

  4. $100B Pledge

    AbbVie commits to $100 billion in U.S. R&D and manufacturing over the next decade.

Stories mentioning TrumpRx 1

market-trends Bullish

AbbVie Commits $380M to U.S. Manufacturing Amid $100B Domestic Pivot

AbbVie has announced a $380 million investment to expand its North Chicago manufacturing campus, marking the first major step in a $100 billion decade-long commitment to U.S. R&D. The initiative aims to localize active pharmaceutical ingredient production while integrating with the Trump administration's 'TrumpRx' program to lower drug costs.

3 sources